Skip to main content

Table 1 seAFOod polyp prevention trial treatment allocation

From: A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial

Placebo Placebo
EPA-FFA 1 g twice daily Placebo
Placebo Aspirin 300 mg once daily
EPA-FFA 1 g twice daily Aspirin 300 mg once daily
\